Combined immunochemotherapy (R-FCM) is superior to chemo-therapy (FCM) alone in recurrent indolent lymphoma - results of a prospective randomized comparison
European Journal of Cancer(2001)
Key words
recurrent indolent lymphoma,combined immunochemotherapy,r-fcm,chemo-therapy
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined